|
|
Business Development
Scientific Advisory Board
|
|
|
|
The Sigma-Aldrich® Scientific Advisory Board is comprised of highly regarded individuals from both academia and industry. The SAB members bring a wide variety of experiences and backgrounds and are valued contributors to our strategic development.
Research Biotechnology Scientific Advisory Board Members:
|
|
David Ornitz, M.D., Ph.D.
Alumni Endowed Professor of Molecular Biology and Pharmacology at Washington University Medical School
|
|
|
Margaret McCormick, Ph.D.
Integra Ventures
|
|
|
Michael Speicher, M.D., Ph.D.
Institute of Medical Biology and Human Genetics
Medical University of Graz
|
|
|
Ross L. Cagan, Ph.D.
Associate Professor, Department of Molecular Biology and Pharmacology at Washington University School of Medicine
|
|
|
Gerald W. Hart, Ph.D.
DeLamar Professor & Director, Department of Biological Chemistry at Johns Hopkins University School of Medicine
|
|
|
Philip Andrews, Ph.D.
Department of Biological Chemistry, University of Michigan
|
|
|
Sheila Stewart, Ph.D.
Assistant Professor of Cell Biology & Physiology and of Medicine, Washington University
|
|
|
Sara Cunningham Hall, Ph.D.
President and CEO, Tacere Therapeutics, Inc.
|
|
|
Warren Chan, Ph.D.
University of Toronto
|
|
|
Arul Chinnaiyan, M.D., Ph.D.
University of Michigan
|
|
|
Robert Copeland, Ph.D.
EpiZyme, Inc.
|
|
|
Thomas Kodadek, Ph.D.
University of Texas-Southwestern Medical Center
|
|
|
Michael Weber, Ph.D.
University of Virginia, Director of UVA Regional Cancer Center
|
|
|
